Please login to the form below

Not currently logged in
Email:
Password:

semaglutide

This page shows the latest semaglutide news and features for those working in and with pharma, biotech and healthcare.

Lilly trumpets Trulicity heart data in face-off with Novo Nordisk

Lilly trumpets Trulicity heart data in face-off with Novo Nordisk

Novo Nordisk launched its weekly GLP-1 agonist rival Ozempic (semaglutide) in the US earlier this year, and says it is growing fast with sales of DKK 804m ($122m) in the

Latest news

More from news
Approximately 7 fully matching, plus 18 partially matching documents found.

Latest Intelligence

  • Oral biologics delivery still elusive Oral biologics delivery still elusive

    Novo Nordisk is also working with another specialist on oral delivery for protein drugs - Emisphere Technologies - that has applied its Eligen technology to develop an oral version of semaglutide, a

  • Deal Watch table for February 2014 Deal Watch table for February 2014

    Development. Semaglutide once weekly, ZP Patch Technology. 115. Andromeda / Teva Pharmaceutical Industries.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Infographics